PFIZER, INC.

(PFE)
  Report
Real-time Estimate Cboe BZX  -  05/23 03:03:52 pm EDT
52.90 USD   +0.81%
02:20pWall Street rebounds with assist from banks, big tech
RE
02:07pWhat's next for COVID-19 vaccines for youngest US children
AQ
11:48aPfizer says 3 COVID shots protect children under 5
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

PFIZER INC : Barclays reiterates its Neutral rating

01/11/2022 | 08:30am EDT

Initially Neutral on the company, Barclays's analyst Carter Gould maintained his recommendation. The target price remains unchanged at USD 54.


© MarketScreener with dpa-AFX Analyser 2022
Stocks mentioned in the article
ChangeLast1st jan.
ON SEMICONDUCTOR CORPORATION -1.10% 55.65 Delayed Quote.-16.87%
PFIZER, INC. 1.13% 53.05 Delayed Quote.-11.14%
All news about PFIZER, INC.
02:20pWall Street rebounds with assist from banks, big tech
RE
02:07pWhat's next for COVID-19 vaccines for youngest US children
AQ
11:48aPfizer says 3 COVID shots protect children under 5
AQ
11:43aGLOBAL MARKETS LIVE : Tesla, Kohl's, Apple, JPMorgan, Bank of America...
10:33aWALL STREET STOCK EXCHANGE : Biden comments reassure investors
10:26aPfizer says 3 shots of COVID-19 vaccine for children under 5 about 80% effective
AQ
08:39aWhat you need to know about the coronavirus right now
RE
07:51aPfizer, BioNTech Say Third Dose of COVID-19 Vaccine About 80% Effective in Children Age..
MT
07:20aPfizer, BioNTech Publish Data Supporting COVID-19 Vaccine Efficacy In Children Aged Six..
MT
06:46aPfizer says three COVID-19 vaccine doses protect kids under 5, company plans to give da..
AQ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2022 104 B - -
Net income 2022 35 662 M - -
Net cash 2022 10 478 M - -
P/E ratio 2022 8,75x
Yield 2022 3,09%
Capitalization 294 B 294 B -
EV / Sales 2022 2,73x
EV / Sales 2023 3,55x
Nbr of Employees 79 000
Free-Float 58,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 52,47 $
Average target price 57,66 $
Spread / Average Target 9,89%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
David M. Denton Chief Financial Officer & Executive Vice President
Mikael Dolsten Executive VP, President-Research & Development
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.-11.14%294 404
JOHNSON & JOHNSON3.45%465 705
ELI LILLY AND COMPANY8.19%269 013
ABBVIE INC.11.53%266 851
ROCHE HOLDING AG-15.67%266 707
NOVO NORDISK A/S3.58%245 099